A current controversy in cancer research is whether the rate of accumulatio
n of mutations in normal somatic cells is sufficient to account for the num
ber of mutations in malignant cells. This review will focus on the tg;pes o
f mutations that can occur in mammalian somatic cells and the frequency at
which some of these mutations have been shown to occur in vivo. Human and m
ouse mutation detection systems will be highlighted. The possibility that d
istinct mutational events can arise from a common precursor will be discuss
ed as will the possibility that inherited and sporadic cancers can acquire
mutator phenotypes at different times in tumor development. Consideration w
ill also be given to a potential relationship between an age-related accumu
lation of mutations and cancer.